Gain Therapeutics (GANX) Preferred Shares (2020)
Gain Therapeutics has reported Preferred Shares over the past 1 years, most recently at $118.0 for Q4 2020.
- Quarterly results put Preferred Shares at $118.0 for Q4 2020, changed N/A from a year ago — trailing twelve months through Dec 2020 was $118.0 (changed N/A YoY), and the annual figure for FY2020 was $118.0, changed.
- Preferred Shares for Q4 2020 was $118.0 at Gain Therapeutics.
- Over the last five years, Preferred Shares for GANX hit a ceiling of $118.0 in Q4 2020 and a floor of $118.0 in Q4 2020.